The estimated Net Worth of Peyton R Howell is at least $713 Thousand dollars as of 22 May 2024. Ms. Howell owns over 4,434 units of Tandem Diabetes Care Inc stock worth over $713,164 and over the last 13 years she sold TNDM stock worth over $0. In addition, she makes $0 as Independent Director at Tandem Diabetes Care Inc.
Peyton has made over 29 trades of the Tandem Diabetes Care Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently she exercised 4,434 units of TNDM stock worth $229,371 on 22 May 2024.
The largest trade she's ever made was exercising 48,750 units of Tandem Diabetes Care Inc stock on 5 August 2016 worth over $1,375,725. On average, Peyton trades about 10,667 units every 95 days since 2012. As of 22 May 2024 she still owns at least 16,690 units of Tandem Diabetes Care Inc stock.
You can see the complete history of Ms. Howell stock trades at the bottom of the page.
Peyton R. Howell has been appointed as Independent Director of the Company effective 8/3/2020. Ms. Howell is currently the Chief Commercial and Strategy Officer at Parexel International, a leading global clinical research organization servicing the life sciences industry. Prior to joining Parexel, Ms. Howell held a wide range of senior leadership positions at AmerisourceBergen, including leading Global Sourcing and Manufacturer Relations and advancing specialty and biotech products and solutions for physicians, health systems and specialty pharmacies. She was a founder and President of Lash Group, a patient support services company, and an early pioneer of programs to support patient access, reimbursement, and adherence to new therapies including services related to diabetes, such as patient assistance and reimbursement support for continuous glucose monitors. Ms. Howell was President of Lash Group for nearly a decade following its acquisition by AmerisourceBergen. Ms. Howell is a recognized national speaker on health policy, patient access and reimbursement issues. She has served as Director of the AmerisourceBergen Foundation, the National Association of Chain Drug Stores Foundation, and the Healthcare Distribution Alliance Foundation. Ms. Howell received a Bachelor of Arts in Speech Communication from The University of Illinois, Champaign and a Master's of Health Administration from The Ohio State University.
Peyton Howell is 53, she's been the Independent Director of Tandem Diabetes Care Inc since 2020. There are 10 older and 11 younger executives at Tandem Diabetes Care Inc. The oldest executive at Tandem Diabetes Care Inc is Dick Allen, 75, who is the Lead Independent Director.
Peyton's mailing address filed with the SEC is 12400, High Bluff Drive, San Diego, San Diego County, California, 92130, United States.
Over the last 11 years, insiders at Tandem Diabetes Care Inc have traded over $154,253,951 worth of Tandem Diabetes Care Inc stock and bought 4,118,443 units worth $11,618,906 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Douglas A Roeder, and Nicole Vitullo. On average, Tandem Diabetes Care Inc executives and independent directors trade stock every 9 days with the average trade being worth of $885,878. The most recent stock trade was executed by Shannon Marie Hansen on 15 August 2024, trading 1,968 units of TNDM stock currently worth $84,093.
tandem diabetes care, inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. the company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. tandem manufactures and sells the t:slim x2™ insulin pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® insulin pump, the first pump designed for people with greater insulin requirements. tandem is based in san diego, california. safety information please note that this account is not intended to be used for product support or medical advice. if you are having a medical emergency, please dial 911. if you are having an issue with one of our products and need immediate assistance, please call our 24 hour customer support team at 877-801-6901 and press 1 twice. tandem insulin pumps are intended for the subcutan
Tandem Diabetes Care Inc executives and other stock owners filed with the SEC include: